Early colorectal carcinomas: CD10 expression, mucin phenotype and submucosal invasion

Pathology International

Volumn 62, Issue 9, 2012, Pages 600-611

  Hirano, Kimikazu ^a   Nimura, Satoshi ^a   Mizoguchi, Mikio ^a   Hamada, Yoshihiro ^a   Yamashita, Yuichi ^a   Iwasaki, Hiroshi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

CD10; Colorectal carcinoma; de novo carcinoma; MUC2; MUC5AC; Mucin phenotypes; Non polypoid carcinoma; Submucosal invasion

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MUCIN 2; MUCIN 5AC;

AGED; ARTICLE; CANCER INCIDENCE; CANCER INFILTRATION; CANCER INVASION; CANCER SIZE; CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISTANT METASTASIS; EARLY CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NON POLYPOID CARCINOMA; POLYPOID CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBMUCOSA;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MUCIN 5AC; MUCIN-2; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEPRILYSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84865557138     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2012.02850.x     Document Type: Article

References (35)

1. Helwig EB. The evolution of adenomas of the large intestine and their relation to carcinoma. Surg Gynecol Obstet 1947; 84: 36-49.
2. Morson BC. The polyp cancer sequence in the large bowel. Proc R Soc Med 1974; 67: 451-7.
3. Iwashita A, Haraoka S, Tanabe H. Relationship of colorectal adenoma to colorectal carcinoma-histogenesis of colorectal carcinoma. Intestine 2009; 13: 389-93. (in Japanese).
4. Ikegami M. A pathological study on colorectal cancer. From de novo carcinoma to advanced carcinoma. Acta Pathol Jpn 1987; 37: 21-37.
5. Muto T, Kamiya J, Sawada T etal. Small 'flat adenoma' of the large bowel with special reference to its clinicopathologic features. Dis Colon Rectum 1985; 28: 847-51.
6. Shimoda T, Ikegami M, Fujisaki J, Matsui T, Aizawa S, Ishikawa E. Early colorectal carcinoma with special reference to its development de novo. Cancer 1989; 64: 1138-46.
7. Kudo S, Kashida H, Tamura T. Early colorectal cancer: Flat or depressed type. J Gastroenterol Hepatol 2000; 15 Suppl: D66-70.
8. Kudo S, Tamura S, Hirota S etal. The problem of de novo colorectal carcinoma. Eur J Cancer 1995; 31A: 1118-20.
9. Kuramoto S, Oohara T. Flat early cancers of the large intestine. Cancer 1989; 64: 950-5.
10. Hirota S, Kudo S, Hosobe S etal. p53 immunoreactive stain and early colorectal adenocarcinomas. Eur J Cancer 1995; 31A: 2220-2.
11. Ikeda Y, Mori M, Shibahara K, Iwashita A, Haraguchi Y, Saku M. The role of adenoma for colorectal cancer development: Differences in the distribution of adenoma with low-grade dysplasia, high-grade dysplasia, and cancer that invades the submucosa. Surgery 2002; 131: S105-8.
12. Tsujitani S, Shirai H, Tatebe S etal. Apoptotic cell death and its relationship to carcinogenesis in colorectal carcinoma. Cancer 1996; 77: 1711-6.
13. Wada R, Matsukuma S, Abe H etal. Histopathological studies of superficial-type early colorectal carcinoma. Cancer 1996; 77: 44-50.
14. Kurisu Y, Shimoda T, Ochiai A, Nakanishi Y, Hirata I, Katsu KI. Histologic and immunohistochemical analysis of early submucosal invasive carcinoma of the colon and rectum. Pathol Int 1999; 49: 608-16.
15. Matsui T, Yao T, Yao K etal. Natural history of superficial depressed colorectal cancer: Retrospective radiographic and histologic analysis. Radiology 1996; 201: 226-32.
16. Tatematsu M, Ichinose M, Miki K, Hasegawa R, Kato T, Ito N. Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 1990; 40: 494-504.
17. Yao T, Kajiwara M, Kouzuki T, Iwashita A, Tsuneyoshi M. Villous tumor of the colon and rectum with special reference to roles of p53 and bcl-2 in adenoma-carcinoma sequence. Pathol Int 1999; 49: 374-82.
18. Yao T, Tsutsumi S, Akaiwa Y etal. Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior. Jpn J Cancer Res 2001; 92: 755-61.
19. Yao T, Takata M, Tustsumi S etal. Phenotypic expression of gastrointestinal differentiation markers in colorectal adenocarcinomas with liver metastasis. Pathology 2002; 34: 556-60.
20. Fujimori T, Fujii S, Saito N, Sugihara K. Pathological diagnosis of early colorectal carcinoma and its clinical implications. Digestion 2009; 79 Suppl 1: 40-51.
21. Hanski C, Riede E, Gratchev A etal. MUC2 gene suppression in human colorectal carcinomas and their metastases: In vitro evidence of the modulatory role of DNA methylation. Lab Invest 1997; 77: 685-95.
22. Iwase T, Kushima R, Mukaisho K, Mitsufuji S, Okanoue T, Hattori T. Overexpression of CD10 and reduced MUC2 expression correlate with the development and progression of colorectal neoplasms. Pathol Res Pract 2005; 201: 83-91.
23. Kang H, Min BS, Lee KY etal. Loss of E-cadherin and MUC2 expressions correlated with poor survival in patients with stages II and III colorectal carcinoma. Ann Surg Oncol 2011; 18: 711-9.
24. Bartman AE, Sanderson SJ, Ewing SL etal. Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer 1999; 80: 210-8.
25. Fujimoto Y, Nakanishi Y, Sekine S etal. CD10 expression in colorectal carcinoma correlates with liver metastasis. Dis Colon Rectum 2005; 48: 1883-9.
26. Ohji Y, Yao T, Eguchi T etal. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: Multivariate analysis of clinicopathological and immunohistochemical factors. Oncol Rep 2007; 17: 525-30.
27. Yasuda M, Itoh J, Satoh Y etal. Availability of CD10 as a Histopathological Diagnostic Marker. Acta Histochem Cytochem 2005; 38: 17-24.
28. Koga Y, Yao T, Hirahashi M etal. Flat adenoma-carcinoma sequence with high-malignancy potential as demonstrated by CD10 and beta-catenin expression: A different pathway from the polypoid adenoma-carcinoma sequence. Histopathology 2008; 52: 569-77.
29. Hamilton SR, Aaltonen LA. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press, 2001.
30. Japanese Research Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal Carcinoma, 1st English edn. Tokyo: Kanehara, 1997.
31. Watanabe H, Ajioka Y. Pathology of borderline lesion in the large intestine. Byori to Rinsho 1988; 6: 1280-92. (in Japanese).
32. Schlemper RJ, Riddell RH, Kato Y etal. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-5.
33. Maeo S, Ajioka Y, Watanabe H, Kobayashi M. The proliferating cell nuclear antigen (PCNA) index correlates with the grade of cytologic atypia in well-differentiated early adenocarcinomas of the large intestine. Pathol Int 1995; 45: 359-65.
34. Kocer B, Soran A, Erdogan S etal. Expression of MUC5AC in colorectal carcinoma and relationship with prognosis. Pathol Int 2002; 52: 470-7.
35. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A 1995; 92: 3046-50.